Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 54: 1290-1297, 2008. First published June 12, 2008; 10.1373/clinchem.2008.105841
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2008.105841v1
54/8/1290    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thienpont, L. M.
Right arrow Articles by Sluss, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thienpont, L. M.
Right arrow Articles by Sluss, P. M.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2008;54:1290-1297.)
© 2008 American Association for Clinical Chemistry, Inc.


Endocrinology and Metabolism

State-of-the-Art of Serum Testosterone Measurement by Isotope Dilution–Liquid Chromatography– Tandem Mass Spectrometry

Linda M. Thienpont1,a, Katleen Van Uytfanghe1, Stuart Blincko2, Carol S. Ramsay3, Hui Xie3, Robert C. Doss3, Brian G. Keevil4, Laura J. Owen4, Alan L. Rockwood5,6, Mark M. Kushnir5, Kelly Y. Chun7, Donald W. Chandler7, Helen P. Field8 and Patrick M. Sluss9

1 Laboratory for Analytical Chemistry, Faculty of Pharmaceutical Sciences, Gent University, Gent, Belgium; 2 Abbott Diagnostics, Dartford, Kent, UK; 3 Abbott Diagnostics, Abbott Park, IL; 4 Department of Biochemistry, University Hospital of South Manchester, Manchester, UK; 5 ARUP Laboratories, Salt Lake City, UT; 6 Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT; 7 Esoterix Inc., Calabasas Hills, CA; 8 Department of Clinical Biochemistry, Old Medical School, Leeds General Infirmary, Leeds, UK; 9 Clinical Pathology Core Laboratory, Massachusetts General Hospital, Boston, MA.

aAddress correspondence to this author at: Laboratory for Analytical Chemistry, Faculty of Pharmaceutical Sciences, Gent University, Harelbekestraat 72, B-9000 Gent, Belgium. Fax +32-9-264.81.98; e-mail linda.thienpont{at}ugent.be.

Background: The recent interest of clinical laboratories in developing serum testosterone assays based on isotope dilution–liquid chromatography–tandem mass spectrometry (ID-LC-MS/MS) stems from the lack of accuracy of direct immunoassays. In this study, we assessed the accuracy and state of standardization (traceability) of 4 published ID-LC-MS/MS procedures in a method comparison with an ID–gas chromatography (GC)–MS reference measurement procedure listed in the database of the Joint Committee for Traceability in Laboratory Medicine.

Methods: The study used 58 specimens from different patient categories. Each specimen was measured in triplicate (ID-LC-MS/MS) and quadruplicate (ID-GC-MS) in independent runs.

Results: The testosterone concentrations by ID-GC-MS were 0.2–4.4 nmol/L (women), 0.2–2.0 nmol/L (hypogonadal man), and 10.1–31.3 nmol/L (normogonadal men). For ID-GC-MS, the CV was nearly constant, with a median of 1.0%; for ID-LC-MS/MS, it was concentration-dependent, with a median of up to 8%. Weighted Deming regression gave mean slopes, intercepts, and correlation coefficients of 0.90–1.11, –0.055–0.013 nmol/L, and 0.993–0.997, respectively. The % difference plot showed between 7% and 26% of the results outside a total error limit of 14%, with median deviations from ID-GC-MS between –9.6 and 0.4%.

Conclusions: This study demonstrated fairly good accuracy and standardization of the tested ID-LC-MS/MS procedures. Performance differences between procedures were evident in some instances, due to improper calibration and between-run calibration control. This emphasizes the need for thorough validation, including traceability, of new ID-LC-MS/MS procedures.




The following articles in journals at HighWire Press have cited this article:


Home page
Hum ReprodHome page
M. E. Lujan, T. G. Bloski, D. R. Chizen, D. C. Lehotay, and R. A. Pierson
Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome
Hum. Reprod., January 1, 2010; 25(1): 204 - 211.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.